ATE310089T1 - Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen - Google Patents

Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen

Info

Publication number
ATE310089T1
ATE310089T1 AT00956336T AT00956336T ATE310089T1 AT E310089 T1 ATE310089 T1 AT E310089T1 AT 00956336 T AT00956336 T AT 00956336T AT 00956336 T AT00956336 T AT 00956336T AT E310089 T1 ATE310089 T1 AT E310089T1
Authority
AT
Austria
Prior art keywords
white spot
spot syndrome
syndrome virus
derived proteins
virus derived
Prior art date
Application number
AT00956336T
Other languages
English (en)
Inventor
Hulten Maria Cornelia Wilh Van
Justinus Maria Vlak
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE310089T1 publication Critical patent/ATE310089T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00956336T 1999-08-03 2000-07-26 Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen ATE310089T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99202545 1999-08-03
EP00200248 2000-01-24
PCT/EP2000/007290 WO2001009340A1 (en) 1999-08-03 2000-07-26 Proteins derived from white spot syndrome virus and uses thereof

Publications (1)

Publication Number Publication Date
ATE310089T1 true ATE310089T1 (de) 2005-12-15

Family

ID=26071765

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956336T ATE310089T1 (de) 1999-08-03 2000-07-26 Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen

Country Status (14)

Country Link
US (2) US7749506B2 (de)
EP (1) EP1206550B1 (de)
JP (1) JP4786093B2 (de)
CN (2) CN1170934C (de)
AT (1) ATE310089T1 (de)
AU (1) AU771049B2 (de)
BR (1) BR0012919A (de)
CA (1) CA2380833C (de)
DE (1) DE60024100D1 (de)
EC (1) ECSP093601A (de)
MX (1) MXPA02001223A (de)
MY (1) MY131143A (de)
TW (1) TWI266802B (de)
WO (1) WO2001009340A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1366169A2 (de) * 2000-09-15 2003-12-03 Akzo Nobel N.V. Antigenische proteine von shrimp white spot syndrome virus und deren verwendungen
WO2003000900A1 (en) * 2001-06-22 2003-01-03 Akzo Nobel N.V. White spot syndrome virus vaccine
US7550647B2 (en) 2001-09-14 2009-06-23 Advanced Bionutrition Transfected shrimp as production systems for therapeutic proteins
EP1545600A4 (de) * 2002-09-16 2006-07-12 Advanced Bionutrition Corp Protein- und peptid-expression für passive immunität
KR100489617B1 (ko) * 2002-09-24 2005-05-17 주식회사 단바이오텍 흰반점바이러스 감염의 예방 및 치료를 위한 수용성 항체단백질 및 이를 포함한 알, 및 이들의 제조방법
US8633028B2 (en) 2003-07-02 2014-01-21 Musc Foundation For Research Development dsRNA induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein
CN101166752A (zh) * 2003-09-09 2008-04-23 艾克博蒂技术公司 抑制白斑综合征病毒(wssv)感染的组合物和方法
CN101023095B (zh) * 2004-07-09 2013-07-03 绿色生命实验室有限公司 基因工程蛋白质p40及其应用
JP2008169131A (ja) * 2007-01-10 2008-07-24 Univ Of Miyazaki 甲殻類急性ウイルス血症に対するｄｎａワクチン
JP5649188B2 (ja) * 2009-07-09 2015-01-07 国立大学法人 宮崎大学 クルマエビ科生物の急性ウイルス血症に対するワクチン
CN101691403B (zh) * 2009-08-03 2011-11-09 中国海洋大学 抗对虾白斑症病毒囊膜蛋白vp28独特型单克隆抗体及其制备方法
WO2011041789A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions
EP2632486A1 (de) 2010-10-27 2013-09-04 Harrisvaccines Inc Verfahren zur schnellen herstellung von impfstoffen für tiere
US10004797B2 (en) 2010-10-27 2018-06-26 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
US8822427B2 (en) 2010-10-27 2014-09-02 Harrisvaccines Methods and compositions to protect aquatic invertebrates from disease
MY153741A (en) * 2010-11-10 2015-03-13 Univ Malaya A method for producing bio-active agent for the prevention of disease caused by white spot syndrome baculovirus complex and a bio-active agent derived thereof
MY161995A (en) * 2010-11-10 2017-05-31 Univ Malaya Vaccine against white spot syndrome virus
CN109517037B (zh) * 2018-10-31 2022-02-08 青岛科技大学 具有白斑综合征病毒抑制作用的多肽及其应用
CN109821013B (zh) * 2018-12-17 2022-06-14 潍坊麦吉迪生物科技有限公司 抗对虾白斑病疫苗及其制备方法
WO2022158453A1 (ja) * 2021-01-20 2022-07-28 国立大学法人静岡大学 Ｗｓｓｖワクチン
CN114600811A (zh) * 2022-04-21 2022-06-10 中国水产科学研究院黄海水产研究所 一种中国对虾核心育种群wssv的净化方法
CN117701777A (zh) * 2024-01-22 2024-03-15 烟台海关技术中心 WSSV检测引物、crRNA、CRISPR组合物、试剂盒及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU674684B2 (en) * 1992-07-20 1997-01-09 Sterno Group LLC, The Gelled organic liquids
US5824535A (en) * 1996-01-17 1998-10-20 Kou; Guang-Hsiung Identification, purification and detection of WSBV (Baculovirus associated with white spot syndrome)
JPH09201196A (ja) * 1996-01-25 1997-08-05 Koyu Kaku 白斑症候群関連バキュロウイルスの同定、精製および検出

Also Published As

Publication number Publication date
US20090068212A1 (en) 2009-03-12
JP4786093B2 (ja) 2011-10-05
US7749506B2 (en) 2010-07-06
CA2380833A1 (en) 2001-02-08
JP2003506338A (ja) 2003-02-18
ECSP093601A (es) 2009-08-28
WO2001009340A1 (en) 2001-02-08
EP1206550A1 (de) 2002-05-22
US8114977B2 (en) 2012-02-14
AU6832000A (en) 2001-02-19
CN1367834A (zh) 2002-09-04
US20100324125A1 (en) 2010-12-23
CN1170934C (zh) 2004-10-13
BR0012919A (pt) 2002-04-23
EP1206550B1 (de) 2005-11-16
DE60024100D1 (de) 2005-12-22
TWI266802B (en) 2006-11-21
CA2380833C (en) 2011-03-15
MY131143A (en) 2007-07-31
AU771049B2 (en) 2004-03-11
CN1626241A (zh) 2005-06-15
MXPA02001223A (es) 2002-07-30

Similar Documents

Publication Publication Date Title
ATE310089T1 (de) Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
ATE427116T1 (de) Behandlung von bakteriellen infektionen
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
AP1770A (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their sythesis.
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
HUP0002224A1 (hu) Virusellenes hatású benzimidazol-származékok
CY1106334T1 (el) Βελτιστοποιημενου κωδικονιου αλληλουχιες ιου θηλωματος
EP1408986A4 (de) Proteomimetische verbindungen und verfahren
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
MXPA03000626A (es) Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de la hepatitis c.
BRPI0309631A8 (pt) vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3 e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4
EA200200820A1 (ru) Пептиды, полученные из казеина, и их применение в терапии
DE60225556D1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
EA200500019A1 (ru) Ксиланазы, кодирующие их нуклеиновые кислоты и способы их получения и применения
PT1411908E (pt) Tratamento de infeccoes da unha com no
ATE382685T1 (de) Bakteriophagen-lysin
ATE412666T1 (de) Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität
TR200102024T2 (tr) Yeni tedavi.
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
IS5956A (is) Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
ATE411812T1 (de) Peptide zur behandlung von infektionen mit dem herpes-virus
EA200500533A1 (ru) Пептидные производные - ингибиторы слияния при вич-инфекции
FR2804127B1 (fr) Gene srn1 implique dans le syndrome nephrotique cortico- resistant, proteine codee par ce gene et utilisations diagnostiques et therapeutiques

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties